Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2475 of 3173 entries
View as:

A Study To Understand How The Body Reacts To A Low Dose Of PF-06427878 When Given In A Vein To Healthy, Adult, Males

Phase: N/A Priority: Normal
NCT ID: NCT02237742 Org: User:
Start: 11/30/14 End: 12/31/14 Due: 12/31/15

Evaluation Of The Efficacy And Safety Of Single Doses Of PF-05089771 In Patients With Primary (Inherited) Erythromelalgia

Phase: N/A Priority: Normal
NCT ID: NCT01769274 Org: User:
Start: 10/22/12 End: 07/12/13 Due: 07/12/14

A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

Phase: N/A Priority: Normal
NCT ID: NCT06698796 Org: User:
Start: 01/22/25 End: 11/25/27 Due: 11/25/28

An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study

Phase: N/A Priority: Normal
NCT ID: NCT05192200 Org: User:
Start: 12/20/21 End: 11/20/23 Due: 11/20/24

PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03269136 Org: User:
Start: 11/29/17 End: 01/19/24 Due: 01/19/25

Effects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05626322 Org: User:
Start: 08/04/23 End: 05/01/25 Due: 05/01/26

Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532

Phase: N/A Priority: Normal
NCT ID: NCT01369602 Org: User:
Start: 07/31/11 End: 02/29/12 Due: 02/28/13

Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)

Phase: N/A Priority: Normal
NCT ID: NCT05522556 Org: User:
Start: - End: - Due: -

Study Of Sunitinib In Combination With Folfox In Patients With Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00631410 Org: User:
Start: 01/31/08 End: 03/31/10 Due: 03/31/11

A Study to Learn How the Study Medicine (Ponsegromab) is Changed and Eliminated From Healthy Chinese Adults

Phase: N/A Priority: Normal
NCT ID: NCT05685264 Org: User:
Start: 01/18/23 End: 07/07/23 Due: 07/07/24

A Study Evaluating Relative Bioavailability of an Oral Suspension of Abrocitinib and Effect of an Acid Reducing Agent on the Bioavailability of Abrocitinib and Assessing the Taste of Abrocitinib Oral Formulations.

Phase: N/A Priority: Normal
NCT ID: NCT04903093 Org: User:
Start: 06/04/21 End: 10/26/21 Due: 10/26/22

Food Effect Study to Evaluate the Effect of High-Fat Meal on the Relative Bioavailability of PF-07321332 Boosted With Ritonavir in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05129475 Org: User:
Start: 11/12/21 End: 01/12/22 Due: 01/12/23

Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01055496 Org: User:
Start: 03/31/10 End: 03/31/14 Due: 03/31/15

Radiolabeled [14C]PF-02341066 Study To Investigate The Absorption, Metabolism And Excretion In Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01082380 Org: User:
Start: 03/31/10 End: 04/30/10 Due: 04/30/11

A Study To Evaluate PF-05175157 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01433380 Org: User:
Start: 07/31/11 End: 05/31/12 Due: 05/31/13

Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia

Phase: N/A Priority: Normal
NCT ID: NCT00134485 Org: User:
Start: 03/31/05 End: 03/31/06 Due: 03/31/07

Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01719380 Org: User:
Start: 11/23/12 End: 02/12/19 Due: 02/12/20

Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria

Phase: N/A Priority: Normal
NCT ID: NCT00037050 Org: User:
Start: 04/30/02 End: 07/31/05 Due: 07/31/06

A Study Comparing Ceftazidime-Avibactam Versus Meropenem in Hospitalized Adults With Nosocomial Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT01808092 Org: User:
Start: 04/30/13 End: 01/31/16 Due: 01/31/17

A Multi-Center, Randomized, Double-Blind, Parallel Group Study To Compare The Efficacy And Tolerability Of Valdecoxib And Diclofenac In Patients With A Sprained Ankle

Phase: N/A Priority: Normal
NCT ID: NCT00671320 Org: User:
Start: 12/31/02 End: 10/31/03 Due: 10/31/04

A Study Comparing The Amounts of Tafamidis In The Blood With Or Without Food

Phase: N/A Priority: Normal
NCT ID: NCT02406560 Org: User:
Start: 04/30/15 End: 06/30/15 Due: 06/30/16

Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT

Phase: N/A Priority: Normal
NCT ID: NCT00147563 Org: User:
Start: 10/31/03 End: - Due: -

Safety And Efficacy Evaluation Of Fx-1006a In Patients With V122i Or Wild-Type Transthyretin (TTR) Amyloid Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT00935012 Org: User:
Start: 09/30/09 End: 11/20/19 Due: 11/20/20

Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years

Phase: N/A Priority: Normal
NCT ID: NCT00161785 Org: User:
Start: 06/30/04 End: 07/31/05 Due: 07/31/06

A Study to Evaluate GBT021601 in Single and Multiple Doses in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05036512 Org: User:
Start: 12/09/20 End: 02/07/23 Due: 02/07/24